What Researchers Did
Researchers conducted a retrospective review of patients who received hyperbaric oxygen therapy for failing or threatened post-reconstructive flaps to characterize its application and identify treatment variables associated with positive outcomes.
What They Found
Flap survival was achieved in 11 of 15 patients (73.3%) who underwent hyperbaric oxygen therapy for compromised flaps. Of those successfully treated, four (36.4%) healed completely and seven (63.6%) showed marked improvement, with an average flap area improvement of 68.3%. High treatment completion rates (p = 0.022) and high pretreatment transcutaneous oxygen measurements (p = 0.05) were significantly associated with favorable outcomes, while smoking was a negative factor (p = 0.011).
What This Means for Canadian Patients
Canadian patients undergoing reconstructive surgery who experience compromised flaps might benefit from hyperbaric oxygen therapy to improve flap viability. Adhering to the full course of treatment and avoiding smoking could further enhance the chances of successful flap recovery.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
This study was limited by its retrospective design and small sample size of 15 patients.